COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies
Abstract Coronavirus Disease‐19 (COVID‐19) is an infectious disease caused by severe acute respiratory syndrome‐coronaviruses‐2 (SARS‐CoV‐2), a highly pathogenic and transmissible coronavirus. Most cases of COVID‐19 have mild to moderate symptoms, including cough, fever, myalgias, and headache. On t...
Saved in:
| Main Authors: | Ilker Polatoğlu, Tulay Oncu‐Oner, Irem Dalman, Senanur Ozdogan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-04-01
|
| Series: | MedComm |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/mco2.228 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibody-dependent enhancement of SARS-CoV-2, the impact of variants and vaccination
by: Swapna Thomas, et al.
Published: (2025-12-01) -
Protection of Prior SARS-CoV-2 Infection Against Different Variants, Including Omicron Descendants, in a Country with High Viral Transmission
by: Stefan Escobar-Agreda, et al.
Published: (2025-05-01) -
Characterization of binding affinity changes of SARS-CoV-2 omicron variant peptides to population-specific HLA
by: Che-Mai Chang, et al.
Published: (2025-04-01) -
SARS-CoV-2 and Coronaviruses: Understanding Transmission, Impact, and Strategies for Prevention and Treatment
by: Seyede Nafise Tabatabaei, et al.
Published: (2025-02-01) -
SARS-CoV-2 genetic diversity and variants of concern in Saudi Arabia
by: Dalia Abdullah Obeid, et al.
Published: (2021-12-01)